Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic
2020
The emergence of novel Coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).
Keywords:
-
Correction
-
Source
-
Cite
-
Save
12
References
121
Citations
NaN
KQI